Hello Weedman I did not address Washington open
Post# of 56324
Posted On: 06/24/2014 8:20:08 PM
Hello Weedman
I did not address Washington opening stores July 8th because FITX is not in the US Market for mmj although I am sure they do have big hemp plans in the USA. Washington will certainly be an eye opener though because it will ultimately become a matter of supply demand and I think the standards FITX is trying to establish would only benefit the industry as a whole.
HEMP Ltd. I have looked at their general operating plan and IMO their PPS is overvalued when you compare apples to apples here. It's no contest and investors will quickly find that out (my opinion of course)
50 Mil R&D....news to me. haven't heard anything.
FITX uplist. Share structure MUST be addressed before any uplisting could ever occur as well as audited financials and a host of other things but I believe the team FITX has now will aggressively pursue these issues.
I do agree with you generally speaking but stress that the key here really is licensing. There are over 800 applicants for licensing and only about 20 or so will ever become licensed. That means that over 780 "candidates" which includes a number of the OTC listed companies will never become licensed but many investors will still place their money on these companies. It is far better to bet on the strongest horse in the race. All my opinion of course.
Thanks for your response. It's nice to hear from you
I did not address Washington opening stores July 8th because FITX is not in the US Market for mmj although I am sure they do have big hemp plans in the USA. Washington will certainly be an eye opener though because it will ultimately become a matter of supply demand and I think the standards FITX is trying to establish would only benefit the industry as a whole.
HEMP Ltd. I have looked at their general operating plan and IMO their PPS is overvalued when you compare apples to apples here. It's no contest and investors will quickly find that out (my opinion of course)
50 Mil R&D....news to me. haven't heard anything.
FITX uplist. Share structure MUST be addressed before any uplisting could ever occur as well as audited financials and a host of other things but I believe the team FITX has now will aggressively pursue these issues.
I do agree with you generally speaking but stress that the key here really is licensing. There are over 800 applicants for licensing and only about 20 or so will ever become licensed. That means that over 780 "candidates" which includes a number of the OTC listed companies will never become licensed but many investors will still place their money on these companies. It is far better to bet on the strongest horse in the race. All my opinion of course.
Thanks for your response. It's nice to hear from you
(0)
(0)